Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content
Environmental Health PHGKB

Specific PHGKB|Environmental Health PHGKB|Public Health Genomics and Precision Health Knowledge Base (PHGKB)

Last Posted: Apr 20, 2024
spot light Spotlight

Many roads to a gene-environment interaction.
Kenneth E Westerman et al. Am J Hum Genet 2024 4 (4) 626-635 (Posted Apr 10, 2024 8AM)

From the abstract: "Despite the importance of gene-environment interactions (GxEs) in improving and operationalizing genetic discovery, interpretation of any GxEs that are discovered can be surprisingly difficult. There are many potential biological and statistical explanations for a statistically significant finding and, likewise, it is not always clear what can be claimed based on a null result. Here, we provide a detailed explanation of five “phenomena,” or data-generating mechanisms, that can lead to nonzero interaction estimates, as well as a discussion of specific instances in which they might be relevant. "

Challenges and opportunities for Lynch syndrome cascade testing in the United States.
Lauren E Passero et al. Fam Cancer 2024 3 (Posted Apr 02, 2024 10AM)

From the abstract: " Lynch syndrome is an underdiagnosed genetic condition that increases lifetime colorectal, endometrial, and other cancer risk. Cascade testing in relatives is recommended to increase diagnoses and enable access to cancer prevention services, yet uptake is limited due to documented multi-level barriers. Individual barriers such as feelings of fear, guilt, and anxiety and limited knowledge about Lynch syndrome as well as interpersonal barriers including complex family dynamics and language barriers limit family communication about Lynch syndrome and prevent uptake of genetic screening for relatives. Organizational and environmental barriers including a shortage of genetics professionals, high costs, and fears of discrimination also reduce cascade testing. These multi-level barriers may disproportionately impact underserved populations in the United States,"

Amyotrophic lateral sclerosis: translating genetic discoveries into therapies.
Fulya Akçimen et al. Nat Rev Genet 2023 4 (9) 642-658 (Posted Mar 27, 2024 1PM)

From the abstract: "Recent advances in sequencing technologies and collaborative efforts have led to substantial progress in identifying the genetic causes of amyotrophic lateral sclerosis (ALS). This momentum has, in turn, fostered the development of putative molecular therapies. In this Review, we outline the current genetic knowledge, emphasizing recent discoveries and emerging concepts such as the implication of distinct types of mutation, variability in mutated genes in diverse genetic ancestries and gene–environment interactions. "

Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?
Benjamin Cross et al. Pharmacogenomics J 2024 3 (2) 7 (Posted Mar 12, 2024 0PM)

From the abstract: "This review seeks to highlight the genetic, environmental and clinical factors associated with variability in anticoagulant response, and review the current evidence base for tailoring the drug, dose, and/or monitoring decisions to identified patient subgroups to improve anticoagulant safety. Areas that would benefit from further research are also identified. Validated variants in VKORC1, CYP2C9 and CYP4F2 constitute biomarkers for differential warfarin response and genotype-informed warfarin dosing has been shown to reduce adverse clinical events. "


news Latest News and Publications
Temporal assessment of SARS-CoV-2 detection in wastewater and its epidemiological implications in COVID-19 case dynamics. External Web Site Icon
Li Lin, et al. Heliyon 2024 0 0. (8) e29462
Combining wastewater surveillance and case data in estimating the time-varying effective reproduction number. External Web Site Icon
Jin Shihui, et al. The Science of the total environment 2024 0 0. 172469
Development of a Non-Invasive Machine-Learned Point-of-Care Rule-Out Test for Coronary Artery Disease. External Web Site Icon
Timothy Burton et al. Diagnostics (Basel) 2024 14(7)
Infodemiology of Influenza-like Illness: Utilizing Google Trends' Big Data for Epidemic Surveillance. External Web Site Icon
Dong-Her Shih et al. J Clin Med 2024 13(7)
Use of artificial intelligence in critical care: opportunities and obstacles. External Web Site Icon
Michael R Pinsky et al. Crit Care 2024 28(1) 113
Computational methods in the analysis of SARS-CoV-2 in mammals: A systematic review of the literature. External Web Site Icon
Paula Vitória Silva et al. Comput Biol Med 2024 4 108264
CovMediScanX: A medical imaging solution for COVID-19 diagnosis from chest X-ray images. External Web Site Icon
Nair Smitha Sunil Kumaran, et al. Journal of medical imaging and radiation sciences 2024 0 0.
Predicting outcomes of the acute phase of COVID-19. High sensitive prognostic model, based on the results of the international registry "analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients" (ACTIV). External Web Site Icon
Arutyunov Gregory P, et al. Heliyon 2024 0 0. (7) e28892
Transit communication via Twitter during the COVID-19 pandemic. External Web Site Icon
Zhang Wenwen, et al. Environment and planning. B, urban analytics and city science 2024 0 0. (5) 1244-1261
Using mobile phone big data to discover the spatial patterns of rural migrant workers' return to work in China's three urban agglomerations in the post-COVID-19 era. External Web Site Icon
Liu Kai, et al. Environment and planning. B, urban analytics and city science 2024 0 0. (4) 878-894

More


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

TOP